Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting ...

Background Transjugular intrahepatic portosystemic shunt (TIPS) is a minimally invasive therapeutic option to treat complications of portal hypertension. TIPS can provide long-term symptom control and ...

Background and Aims Transjugular intrahepatic portosystemic shunts (TIPSS) are increasingly used for the management of portal hypertensive complications. Outcomes for patients undergoing TIPSS for the ...

BNP Chairperson Khaleda Zia will be taken to London first and then to another country for advanced treatment very soon, if ...

Total paracentesis has also been shown to be as safe as repeated partial paracentesis and to shorten the period of hospitalization -- and may even be performed on an outpatient basis. [34] However ...

Considering her health condition, we have started preparations to transfer her to a multidisciplinary hospital abroad as quickly as possible, her personal physician Professor AZM Zahid Hossain says ...

Last week, BioVie announced a significant milestone: a Notice of Allowance from the Japan Patent Office for its application regarding a novel liquid formulation of terlipressin. This formulation, ...

Patients with refractory ascites or GI bleeding may benefit from the surgical placement of shunts between the portal and systemic circulation. For example, a transjugular intrahepatic portosystemic ...

Portal hypertension is an abnormal increase in blood pressure defined clinically as hepatic venous pressure gradient 5 mmHg in the hepatic portal vein system. Causes of portal hypertension ...

For example, a transjugular intrahepatic portosystemic shunt (TIPS) is a shunt placed inside the liver that carries blood ...